← Eichor
Condition: Idiopathic Cd4 Lymphocytopenia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Idiopathic Cd4 Lymphocytopenia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 L
Phase 1/Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05600920Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00867269Predictive Performance of a Generative Model for Corneal Tomography After ICL Implantation
Phase N/A · 1 location(s) · Second Affiliated Hospital of Nanchang University · NCT07146737Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04097561Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T
Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT02015013
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.